G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation  by Ruijtenberg, Suzan & van den Heuvel, Sander
Article
G1/S Inhibitors and the SWI/SNF Complex Control
Cell-Cycle Exit during Muscle DifferentiationGraphical AbstractHighlightsd A combined conditional knockout and lineage-tracing
system for C. elegans
d Quantitative in vivo analysis of cell-cycle exit during
development
d SWI/SNF and G1/S inhibitors provide alternative
mechanisms for cell-cycle arrest
d The SWI/SNF complex prevents tumorous over-proliferation
in C. elegansRuijtenberg & van den Heuvel, 2015, Cell 162, 300–313








remodeling provides an important brake
on cell proliferation in C. elegans,
suggesting an explanation for frequent
mutation of this complex in human
tumors.
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The transition from proliferating precursor cells to
post-mitotic differentiated cells is crucial for develop-
ment, tissue homeostasis, and tumor suppression.
To study cell-cycle exit during differentiation in vivo,
we developed a conditional knockout and lineage-
tracing system for Caenorhabditis elegans. Com-
bined lineage-specific gene inactivation and genetic
screening revealed extensive redundancies between
previously identified cell-cycle inhibitors and the
SWI/SNF chromatin-remodeling complex. Muscle
precursor cells missing either SWI/SNF or G1/S
inhibitor function could still arrest cell division, while
simultaneous inactivation of these regulators caused
continued proliferation and a C. elegans tumor
phenotype. Further genetic analyses support that
SWI/SNF acts in concert with hlh-1 MyoD, antago-
nizes Polycomb-mediated transcriptional repres-
sion, and suppresses cye-1 Cyclin E transcription to
arrest cell division of muscle precursors. Thus, SWI/
SNF and G1/S inhibitors provide alternative mecha-
nisms to arrest cell-cycle progression during terminal
differentiation, which offers insight into the frequent
mutation of SWI/SNF genes in human cancers.INTRODUCTION
The development and maintenance of tissues and organisms
depend on close coordination between cell proliferation and
differentiation. Early embryos contain rapidly proliferating toti-
potent cells, whereas adult tissues predominantly consist of
non-dividing cells with specialized morphologies and functions
(Buttitta and Edgar, 2007). In general, cell specialization involves
a gradual process of lineage restriction, followed by permanent
exit from the division cycle and terminal differentiation. The
mechanisms that arrest cell proliferation during differentiation
are crucial for tumor suppression but limit tissue regeneration.
Despite this importance, it remains poorly understood how cell
proliferation and differentiation are inversely regulated during
development, and how temporary quiescence differs from per-
manent cell-cycle arrest.
The primary mechanism to arrest cell division is inhibition of
cyclin-dependent kinases (CDKs), the key positive regulators300 Cell 162, 300–313, July 16, 2015 ª2015 Elsevier Inc.of the cell division cycle. CDK4/6-cyclin D and CDK2-cyclin E ki-
nases promote cell-cycle entry during the G1 phase of the cell
cycle (van den Heuvel and Dyson, 2008). Various levels of regu-
lation counteract CDK-cyclin activation to prevent unscheduled
progression from G1 into S phase. G1/S inhibitors include mem-
bers of the retinoblastoma tumor suppressor (Rb) protein family,
which act as transcriptional repressors together with E2F tran-
scription factors. Phosphorylation of pRb by active CDKs trig-
gers its release from E2F and allows activating E2Fs to induce
transcription of cyclin E and other cell-cycle genes. In addition,
CDK inhibitory proteins (CKIs) oppose G1/S progression. CKIs
of the INK4 protein family, such as p16INK4A, associate with
CDK4/6 kinases and prevent their interaction with D-type cy-
clins. In contrast, CKIs of the CIP/KIP family associate with
CDK-cyclin complexes and are particularly important for inhibit-
ing CDK2-cyclin E. Ubiquitin-dependent protein degradation
provides yet another level of G1/S inhibition. This involves the
Anaphase Promoting Complex/Cyclosome (APC/C) in associa-
tion with the FZR1/Cdh1 coactivator, as well as Skp1, Cullin,
F-box factor (SCF) complexes. APC/C and SCF are both E3
ubiquitin ligases that target cell-cycle regulatory proteins for
degradation.
Cell differentiation is ultimately determined at the level of gene
expression. As a well-studied example, muscle differentiation
involves a regulatory network of MyoD and other myogenic
transcription factors, together with general transcription factors
and histone modification/chromatin remodeling complexes
(Puri andMercola, 2012). Other transcription factors mediate dif-
ferentiation into, for instance, specific blood cell types or neu-
rons. Mutations associated with human cancer frequently affect
cell-cycle regulators, but also transcription factors andchromatin
regulators with critical functions in differentiation (Kandoth et al.,
2013). In particular, transcriptional repressors and activators of
the polycomb group (PcG) and Trithorax group (TrxG), respec-
tively, are strongly associated with cell fate and tumor formation.
In fact,mutations in a subclassof TrxGgenes,which encode sub-
units of Switch/Sucrose nonfermentable (SWI/SNF) chromatin
remodeling complexes, were recently found among the most
common mutations in human cancer (Kadoch et al., 2013; Kan-
doth et al., 2013; Wang et al., 2014). These findings highlight
the importance of understanding how the combinatorial activity
of cell-cycle regulators, transcription factors, and chromatin re-
modelers coordinate cell-cycle arrest and differentiation.
The nematode Caenorhabditis elegans provides an attractive
animal system in which to study the control of cell-cycle exit dur-
ing development. C. elegans develops through a highly repro-
ducible pattern of cell proliferation and differentiation (Sulston
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Figure 1. Lineage Tracing and Tissue-
Specific Knockout in C. elegans
(A) Overview of the CRE-lox based recombination
system, which combines tissue-specific gene
inactivation with switching mCherry to eGFP
expression to allow lineage tracing. The single-
copy integrated plasmid without gene of interest
is used as a recombination reporter (readoutlox).
Peft-3::tagBFP, swsn-1, and fzr-1 were studied as
genes of interest.
(B) Examples of lineage-specific recombination
and lineage tracing following tissue-specific CRE
expression from the indicated promoters. Arrows
indicate cells that switched mCherry to eGFP
expression.
(C) CRE-lox-based recombination causes loss of
expression of a tagBFP reporter gene of interest
(A), single copy integrated into the genome. CRE
expressed from the indicated promoters resulted
in loss of mCherry and tagBFP expression, while
eGFP was induced (indicated by arrows). Asterisk
(*) indicates mCherry-negative intestinal cell with
residual tagBFP fluorescence.
Scale bar, 20 mm. See also Figures S1 and S2 and
Tables S1 and S2.and Horvitz, 1977; Sulston et al., 1983). The animal’s transpar-
ency and well-described lineage allow characterization of mu-
tants with single-cell resolution. Extra cell division (hyperplasia)
of somatic cells was first observed in the lineage-abnormal mu-
tants lin-23 b-TrCP and cul-1 (lin-19), which lack the function
of an SCF-like E3 ubiquitin ligase (Kipreos et al., 1996, 2000).
Loss of cki-1 Kip1 also results in extra cell division (Boxem and
van den Heuvel, 2001; Fukuyama et al., 2003; Hong et al.,
1998). In contrast, mutation of the single C. elegans Rb-related
gene, lin-35, or the APC/C coactivator fzr-1 FZR1/Cdh1 leads
to substantial hyperplasia only when combined with loss of other
negative cell-cycle regulators (Boxem and van denHeuvel, 2001;
Fay et al., 2002). Notably, such double mutants still form
apparently normal differentiated post-mitotic cells, and uncon-
trolled over-proliferation of somatic cells has thus far not been
described for C. elegans.
To study cell-cycle arrest during the process of differentiation,
we created a system for tissue-specific gene inactivation and
lineage tracing. This allowed inactivation of multiple genes in a
single precursor cell, while fluorescently marking all daughterCell 162, 300–cells. Combining this system with RNAi
of candidate genes revealed multiple
levels of control that together provide
robust arrest of cell division during termi-
nal differentiation. We observed a surpris-
ing degree of redundancy between well-
knownnegative regulators of the cell cycle
and the SWI/SNF chromatin-remodeling
complex. Only combined inactivation of
the SWI/SNF complex andG1/S inhibitors
resulted in tumorous over-proliferation of
muscle precursor cells. Our results sup-
port that SWI/SNF-dependent chromatinremodeling provides global transcriptional control not only of
cell-type-specific genes, but also of positive and negative cell-
cycle regulators. This provides an alternativemechanism for con-
trol of cell-cycle exit during terminal differentiation and likely is
relevant for the tumor suppressor function of SWI/SNF genes.
RESULTS
A CRE-Lox Based Recombination and Lineage-Tracing
System for C. elegans
We assumed that cell-cycle withdrawal during differentiation
depends on multiple regulators and is essential for viability.
Hence, to genetically dissect developmental control of cell-
cycle exit, we aimed to induce multiple gene alterations in a line-
age-specific manner. Hereto, we developed a CRE-lox-based
recombination and lineage-tracing system for C. elegans (Fig-
ure 1A). This system combines a recombination vector that
includes a gene of interest, a homozygous genomic mutation
of the gene, and tissue-specific expression of the CRE recombi-
nase. This allows tissue-specific gene loss and simultaneous313, July 16, 2015 ª2015 Elsevier Inc. 301
visualization of knockout cells by altered expression of fluores-
cent proteins.
Westartedwitha recombination-reporter (readoutlox) construct
that expresses the mCherry fluorescent protein from the univer-
sally active ribosomal subunit rps-27 promoter (Figure 1A). LoxP
recombination siteswereplacedupstreamof themCherry coding
sequences and downstream of a polyadenylation/transcriptional
stop signal (let-858 30 UTR). This is followed by eGFP coding
sequences without promoter, causing CRE-induced recombina-
tion to induce a switch from mCherry to eGFP expression (Fig-
ure 1A, bottom). Following extensive optimization of the CRE-
expressing vectors (Supplemental Experimental Procedures),
recombination was highly efficient and observed in nearly all ani-
mals with a readoutlox construct (Table S1).
To examine conditional recombination, we expressed CRE
under the control of a heat-shock-inducible promoter (Phsp-
16.2) and a variety of promoters with lineage-specific activity.
Recombination was readily detected by expression of eGFP,
coincident with mCherry loss, and occurred in the expected lin-
eages in nearly all animals (Figure 1B; data not shown). Depen-
dent on the promoter used, additional cell types sometimes
showed eGFP expression (Table S1). For instance, early embry-
onic expression of CRE from the elt-2GATA4-6 and hlh-8 TWIST
promoters induced recombination as expected in the intestine
and mesoblast (M) lineage, respectively. However, both pro-
moters showed some additional activity in the somatic gonad,
and Phlh-8::CRE also induced recombination in embryonic
body-wall muscles (BWM), mostly in the head region of the ani-
mal. In practice, this level of transcriptional noise did not pose a
problem as it usually caused recombination of only one allele (as
concluded from coincident mCherry and eGFP expression) in a
few specific cells.
Several adjustments expanded the versatility of the system.
We introduced alternative lox sites (loxP, loxN, and lox2272) for
reliable recombination of multiple genes in the same cell (Fig-
ure S1; Table S2). Moreover, we created readout constructs
that switch frommCherry to tagBFP expression, to allow lineage
tracing in combination with use of GFP-reporter transgenes (Fig-
ure S1). Finally, we tested whether CRE-induced recombination
is likely to cause loss of function of the gene of interest. DNA
injected into the C. elegans gonad regularly forms multi-copy
arrays that remain present extra-chromosomally (Mello et al.,
1991). To exclude that CRE-lox excised DNA fragments are re-
tained through a similar mechanism, we placed tagBFP coding
sequences flanked by a general promoter (Peft-3) and 30 UTR
(tbb-2 UTR) between the loxP sites in the recombination vector
(Figure 1A). Genomic integration of this vector resulted in animals
with mCherry and tagBFP expression in all somatic cells. Line-
age-specific CRE expression resulted in loss of mCherry and
tagBFP expression (Figure 1C), although tagBFP fluorescence
lasted somewhat longer than mCherry fluorescence. Recombi-
nation could be induced even in post-mitotic cells, based on
eGFP expression and mCherry loss in body-wall muscle, but
tagBFP expression perdured in these cells (Figure 1B; Figure S2).
Thus, cell division likely helps creating a loss of gene functionwith
this approach. In the intestine and mesoblast lineages, tagBFP
was completely absent in all later stage larvae examined. In sum-
mary, CRE-lox-mediated recombination allows efficient lineage-302 Cell 162, 300–313, July 16, 2015 ª2015 Elsevier Inc.specific loss of function in C. elegans, and knockout cells can be
readily visualized based on fluorescent protein expression.
General Inhibitors of G1/S Progression Show Lineage-
Dependent Contributions
We focused our analysis of cell-cycle exit on the intestine and
post-embryonic mesoderm lineage of themesoblast. Nuclear di-
visions in the intestine are sensitive to cell-cycle deregulation
(Boxem and van den Heuvel, 2001, 2002; Korzelius et al.,
2011; Saito et al., 2004), while theM lineage is particularly attrac-
tive for proliferation-differentiation studies. The mesoblast (M) is
formed at approximately 4 hr of embryonic development and re-
mains quiescent until halfway the first larval stage (L1) (Sulston
et al., 1983) (Figure 2A). Cell divisions in L1 generate 16 M
daughter cells that undergo terminal differentiation, and two
ventral precursor cells known as sex myoblasts (SMs). The
SMs migrate anteriorly to align with the gonad during L2 devel-
opment (Figures 2A and 2B) (Sulston and Horvitz, 1977). Starting
in the late L3 stage, each SM goes through three rounds of divi-
sion to form a total of 16 vulval and uterine muscles that are used
for egg laying and are known as sex muscles. Thus, the M line-
age includes multiple periods of proliferation, temporal arrest,
and terminal differentiation over a substantial part of the animal’s
development.
We first examined whether the lin-35 Rb and fzr-1 FZR1/Cdh1
inhibitors of G1/S progression contribute to cell-cycle arrest in
the intestine and M lineage. Inactivation of lin-35 by RNAi or pu-
tative null mutation (n745) combined with fzr-1 loss of function
results in a larval lethal and sterile phenotype, with extra cell
divisions in multiple lineages (Fay et al., 2002). For lineage-spe-
cific loss of function, we placed a fzr-1 genomic fragment in the
reporter plasmid (Figure 1A). Mos1-mediated single-copy inser-
tion (MosSCI) of this plasmid rescued the fzr-1(ku298) strong
loss-of-function mutation, as it restored viability, fertility, and
cell-cycle exit in lin-35(RNAi or n745);fzr-1(ku298) double
mutant larvae (Figures 2C and 3A). For simplicity, we use
fzr-1lox to indicate the combination of fzr-1lox transgene and
fzr-1(ku298) allele (Table S7 lists complete genotypes of all
strains). Intestine-specific CRE expression (Pelt-2::CRE) in lin-
35(RNAi);fzr-1lox animals caused extra division of intestinal
nuclei, similar to the extra intestinal divisions in lin-
35(RNAi);fzr-1(ku298) larvae (Figure 2C; Table S3). In contrast
to the latter, however, lin-35(RNAi) animals with CRE-induced
fzr-1 loss were fully fertile and viable. Thus, validating our sys-
tem, Pelt-2::CRE expression induced intestine-specific fzr-1
inactivation while leaving other tissues unaffected.
Remarkably, examination of the M lineage revealed that lin-35
Rb and fzr-1 are not critical for cell division control in this lineage.
Use of the readoutlox reporter helped determine that lin-35(RNAi
or n745);fzr-1(ku298) double mutants undergo normal temporal
arrest of SMcell division and cell-cycle exit during terminal differ-
entiation (Figure 2D; Table S4). Not surprisingly, lineage-specific
loss of fzr-1lox combined with lin-35 inactivation also did not alter
the cell division and differentiation pattern in the postembryonic
mesoderm lineage (Figure 2D; Table S4). Thus, lin-35 Rb and
fzr-1 show lineage-dependent requirements, and other cell-
cycle regulators are sufficient for temporal and permanent cell-
cycle arrest in the M lineage.
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Figure 2. Lineage-Specific Requirement for lin-35 Rb and fzr-1 FZR1/Cdh1 in Cell-Cycle Arrest
(A) Mesoblast (M) lineage and division pattern in the hermaphrodite. Cell divisions generate 18 M daughter cells in the L1 stage. 16 of these cells differentiate into
body-wall muscle cells and coelomocytes (CC). Two sex myoblasts (SM) migrate anteriorly and divide again in the third larval stage to form muscles required for
egg laying.
(B) Fluorescence microscopy images of mesoblast descendants (eGFP positive, green), visualized by CRE-loxP based recombination of the readoutlox reporter
(Figure 1) following Phlh-8::CRE expression. Arrows: differentiated body-wall muscle. Arrowheads: daughter cells from the SM, *Position of the vulva. Scale bar,
20 mm.
(C and D) Comparison between a homozygous fzr-1(ku298) strong loss-of-function mutant and lineage-specific fzr-1lox knockout. (C) Number of postembryonic
nuclear divisions in the intestine upon inactivation of fzr-1 alone or fzr-1 and lin-35. (D) Number of mesoblast descendants upon inactivation of fzr-1, or fzr-1 and
lin-35, in L2 and L4. Graphs show mean ± SEM; each dot represents a single animal; the dotted line indicates the average number in wild-type (WT).
See also Tables S3 and S4.Reliable Cell-Cycle Arrest through Multiple Levels of
Control
To identify regulators that control temporal cell-cycle exit in
muscle precursor cells, we performed a candidate-based RNAi
screen. This included all genes with a reported cell-cycle inhibi-
tory function in C. elegans as well as transcription factors and
chromatin modifiers with a potential contribution in cell-cycle ar-
rest (Table S5). Gene knockdown by feeding RNAi was tested in
parallel in the M-lineage reporter strain (readoutlox;Phlh-8::CRE)
and in M-lineage double mutant animals lin-35(n745);fzr-
1lox;Phlh-8::CRE (Table S4). We identified six genes that when
singly inactivated by RNAi interfered with M-lineage cell-cycle
exit in the readout control strain. These genes encode the well-
known C. elegans CDK inhibitor CKI-1 Kip1, and two SCF-like
E3 ubiquitin ligase subunits, CUL-1 and LIN-23 b-TrCP (Fig-
ure 3A; Figure S3; Table S4; quantified for sex muscles). In addi-
tion, inhibition of three subunits of the SWI/SNF chromatin-re-modeling complex allowed extra divisions in the M lineage
(Figures 3A and S3; Table S4). Thus, the function of each of these
genes is critical for correct cell-cycle exit in the mesoblast line-
age. At the same time, differentiated muscle cells were still
formed following knockdown of these genes, and the number
of sex muscles at most doubled (Figure 3A).
When tested in combination, the different levels of control
were found to act partly redundantly in promoting cell-cycle
exit. Even though the parental strain lin-35(n745); fzr-
1lox;Phlh-8::CRE showed a normal M-lineage division pattern,
the presence of lin-35 and fzr-1 single or double mutations sub-
stantially increased the numbers of M descendants when com-
bined with RNAi of either cki-1 Kip1, lin-23 b-TrCP, cul-1
Cullin1, or the SWI/SNF genes swsn-1 BAF155/170, swsn-5
(snfc-5) SNF5/INI1, and swsn-2.1 BAF60 (Figures 3A and S2;
Table S4). Specifically, when combined with cki-1(RNAi), the




Figure 3. Cooperative Control of Cell-Cycle Exit by G1/S Inhibitors and SWI/SNF Subunits
(A–D) RNAi of the indicated genes combined with lin-35-null mutation and lineage-specific fzr-1 knockout.
(A) Quantification of the number of mesoblast descendants localized around the vulva for the indicated genotypes.
(B) Quantification of the number of intestinal nuclei for the indicated genotypes. Graphs show mean ± SEM. Each dot represents a single animal; the dotted line
indicates the average numbers in WT.
(C and D) Fluorescence microscopy images of mesoblast descendants (eGFP positive). Bracket indicates vulva region. (C) readoutlox;Phlh-8::CRE control animal
with 16 sex muscles. (D) Illustration of animal with a substantial over-proliferation phenotype, following RNAi of cki-1 in lin-35(n745);fzr-1lox;Phlh-8::CRE larvae.
Scale bars represent 20 mm. See also Figure S3, Tables S3, S4, S5, and S6.enhanced the number of M descendants around the vulva,
and the triple gene inactivation resulted in further increased
numbers of cell division (Figures 3A, 3C, 3D, and S3; Table
S4). Similarly, the lin-23 RNAi phenotype was significantly
stronger in lin-35 single mutants, while the strongest effects
were observed in lin-35;fzr-1lox;hlh-8::CRE mutants. Hyperpla-
sia of vulval muscles induced by RNAi of SWI/SNF genes
was enhanced by fzr-1 mutation in the mesoblast lineage (Fig-
ures 3A and S3; Table S4). While the effect of lin-35 mutation
could possibly arise from enhanced RNAi (Wang et al., 2005),
this is not the case for fzr-1 loss.
Comparing the results in the M lineage to the intestine, line-
age-dependent differences were observed again. Only cki-1
RNAi further increased the number of nuclear divisions in the in-
testine of lin-35(n745);fzr-1lox;Pelt-2::CRE double mutants (Fig-
ures 3B and S3; Table S3). RNAi of lin-23 and cul-1 increased
the number of divisions of intestinal nuclei in lin-35(n745) sin-
gle-mutant larvae. By contrast, inactivation of SWI/SNF subunits
did not affect the number of divisions in the intestine (Figures 3B
and S3; see Discussion). While the relative contribution of each
regulator varies between cell lineages, these results show that304 Cell 162, 300–313, July 16, 2015 ª2015 Elsevier Inc.multiple levels of control act in cooperation to arrest the cell cycle
both in the intestine and mesoblast lineage.
G1/S Inhibitors Act Largely Redundantly with the SWI/
SNF Complex in Cell-Cycle Exit
To better define SWI/SNF contribution in cell-cycle control, we
examined additional mutant combinations. SWI/SNF compo-
nents form highly conserved chromatin remodeling complexes
that use ATPase activity to remodel nucleosome positions,
thereby increasing or reducing access to transcriptional regula-
tors (reviewed in Wilson and Roberts, 2011). The complexes
contain several core subunits, including an ATPase subunit
known as Brahma (BRM) in Drosophila, human BRM (hBRM)
and BRM-Related Gene 1 (BRG1), and SWSN-4 in C. elegans.
BRM/BRG1-associated factors (BAFs) include other core sub-
units (swsn-1 BAF155/170 and swsn-5 BAF47/SNF5/INI1 in
C. elegans), as well as additional accessory and signature sub-
units (Table S6) (Riedel et al., 2013; Sawa et al., 2000; Shibata
et al., 2012). Based on signature subunit composition, two
different complexes, BAF and PBAF, have been distinguished.
While swsn-4 was not present in our RNAi libraries, the other
SWI/SNF core subunits swsn-1 and swsn-5, as well as the
accessory subunit swsn-2.1 (BAF60/SMARCD3), were found to
induce extra M-lineage divisions in our screen (Figure S3; Table
S5). RNAi for three different PBAF-specific components (pbrm-1
BAF180/Polybromo, swsn-7 BAF200/ARID2, swsn-9 BRD7) did
not result in a cell division phenotype (Table S5). Thus, SWI/
SNF activity, and possibly specifically a C. elegans BAF-related
complex, appears to contribute to cell-cycle arrest.
As loss of SWI/SNF-complex function is incompatible with
viability, we created lineage-specific knockout strains for further
analysis. For technical reasons, we focused on the swsn-1(os22)
temperature-sensitive allele, which causes strong loss of func-
tion at the non-permissive temperature of 25C, while being
viable at 15C (Supplemental Experimental Procedures). Similar
to the effect of swsn-5 RNAi, shift of swsn-1lox;Phlh-8::CRE em-
bryos from 15 to 25C increased the number of M descendants
(Figure 4A; Figure S3; note that swsn-1lox refers to the combined
swsn-1(os22) mutation and swsn-1lox single-copy rescuing
transgene). Combining swsn-1 inactivation with single lin-35,
cki-1, or fzr-1 mutation or RNAi further increased the number
of M descendants (Figure 4A). Remarkably, lineage-specific
inactivation of swsn-1 combined with RNAi of either cul-1 or
lin-23 resulted in a massive increase in M-lineage descendants,
which was further enhanced by fzr-1 inactivation (Figures 4B and
4C; Figure S4; Table S4). Similarly, swsn-1lox;Phlh-8::CRE com-
bined with lin-35(n745) and cki-1(RNAi) resulted in a dramatic
over-proliferation phenotype, which was even stronger when
combined with fzr-1lox (Figures 4B, 4D, and S4; Table S4). While
the use of non-null allelesmay contribute to this enhanced effect,
the limited over-proliferation observed after severe knockdown
of individual SWI/SNF genes or G1/S inhibitors stood in stark
contrast with the phenotype of combined mutants (Figures 2,
3, and 4). Even double or triple loss of function of the canonical
G1/S inhibitors caused limited defects, which were greatly
enhanced by simultaneous swsn-1 inhibition. These results
demonstrate that the SWI/SNF complex and G1/S inhibitors
provide substantially overlapping contributions in promoting
cell-cycle exit.
Tumorous Over-Proliferation of Somatic Cells in
C. elegans
Several additional observations confirm that the combined inac-
tivation of swsn-1 and previously characterized G1 regulators
causes uncontrolled cell proliferation and a tumorous pheno-
type. First, to examine whether individual cells or large multinu-
cleated cells are formed, we dissected lin-23(RNAi);swsn-
1lox;Phlh-8::CRE animals in iso-osmotic medium. Upon cutting
the cuticle, cells streamed from the carcass, including many in-
dividual green fluorescent cells (Figure 4E). Addition of DAPI did
not result in DNA staining of these eGFP-positive cells in iso-os-
motic medium, while DAPI staining of fixed animals indicates a
normal DNA content of the eGFP positive cells (Figure 4G;
data not shown). This indicates that the M-lineage descendants
contain an intact plasma membrane. Thus, the combined loss of
swsn-1 and G1/S inhibitors leads to the formation of many extra
individual cells.
To further characterize the phenotype, we performed live ob-
servations of single animals by combined immunofluorescenceand differential interference contrast (DIC) microscopy. We
observed increased numbers of M descendant cells in the early
L2 stage, but not before completion of the L1 division pattern
(Figure 4F). We followed M-lineage divisions in four individual
fzr-1lox;swsn-1lox;lin-23(RNAi);Phlh-8::CRE animals from the
moment that eight daughter cells are formed. In all four animals,
apparently normal cell divisions continued in the M lineage,
which resulted in the generation of 18 daughter cells at normal
positions (Figures 2A and 2B). Mutant animals synchronized by
developmental staging all showed 8 to 18 M-derived cells at
12 hr of larval development. In the large majority (22 of 24) of
these larvae, the pattern of M descendants was normal, while
two showed abnormal positioning of M daughters, but no extra
cells. Following the 18-cell stage, divisions in the M lineage
continued in four out of five mutants, while the corresponding
cells in wild-type animals undergo prolonged cell-cycle arrest
(Figure 4F). Extra divisions were observed in every quadrant,
with continued proliferation of daughter cells that normally
become post-mitotic and initiate terminal differentiation at this
stage.
We examined incorporation of the thymidine analog EdU to
visualize DNA synthesis. Combined detection of EdU and immu-
nohistochemical staining of eGFP demonstrated continued DNA
synthesis inM daughters of lineage-specific swsn-1 knockdown,
lin-23(RNAi) larvae (Figure 4G). Quantification of cell numbers by
counting the eGFP-positive cells indicated that the number of M
descendants increased substantially during the L2 stage, and
also during the L3 and L4 stages (Figure 4B). These numbers
approximately doubled again during a 24 hr time span of devel-
opment from L4 into the adult stage, at which time no somatic
cell division takes place in the wild-type (Figure 4B). Reduced
viability and cell disintegration prevented counting at later time
points. Amazingly, some young adults contained well over 300
M-lineage cells, formed from a single precursor in three days
time and corresponding to approximately a third of the somatic
cells in a normal adult animal. Together, these data show that
combined loss of swsn-1 and G1/S inhibitors results in tumorous
over-proliferation in the C. elegans soma.
The SWI/SNF Complex Cooperates with hlh-1 MyoD in
Cell-Cycle Exit
In contrast to the G1/S inhibitors, a function of the SWI/SNF
complex in cell-cycle exit is poorly defined. Previous chromatin
immunoprecipitation (ChIP) experiments identified several thou-
sand C. elegans genes associated with SWI/SNF subunits
(Riedel et al., 2013). Examining the available chromatin immuno-
precipitation (ChIP) data of SWSN-1::GFP and SWSN-4::GFP
(Riedel et al., 2013), we observed SWI/SNF promoter occupancy
at eight out of nine negative regulators of cell-cycle progression,
and three out of eight positive regulators (Figure S5). SWI/SNF-
dependent chromatin remodeling is particularly important for
the coordinated switching of gene expression programs during
lineage commitment (Eroglu et al., 2014; Wilson and Roberts,
2011). As human MyoD acts in concert with SWI/SNF compo-
nents (Puri and Mercola, 2012; de la Serna et al., 2001), the
C. elegans SWI/SNF complex may act together with the
myogenic transcription factors of the M lineage, in particular,






Figure 4. Combined Inactivation of swsn-1 with G1/S Inhibitors Leads to Dramatically Increased Proliferation in the Mesoblast Lineage
(A and B) RNAi of the indicated genes combined with lin-35(n745)-null mutation and lineage-specific inactivation of swsn-1 and fzr-1. (A) Quantification of the
number of mesoblast descendants localized around the vulva. (B) Quantification of the total number of mesoblast descendants of the indicated genotypes in L2
(red), L4 (blue), and adult (green). Graphs show mean ± SEM; each dot represents a single animal; dotted lines in the graphs indicate average WT number.
(C and D) Representative fluorescent images of mesoblast over-proliferation (green, eGFP positive) in animals of indicated mutant genotypes.
(E) Fluorescence microscopy image of cells following dissection of animals as in (D) in iso-osmotic medium.
(F) Graphical illustrations of lineage analysis of proliferation patterns in young fzr-1lox; swsn-1lox; lin-23(RNAi) animals, based on combined immunofluorescence
and DIC microscopy. Animals containing 18 posterior myoblast daughter cells (as in WT) were imaged every 30 min to follow the initial steps of the over-
proliferation phenotype.Only the left half of the animals, with nineM-daughter cells, are shown in the cartoons. Dark blue, light blue, and green circles: cells formed
during the first 30min of imaging, between 30 and 60min, or between 60 and 90min after the start of the experiment, respectively. Gray cell indicates the initial SM.
(G) Incorporation of EdU (red) in mutant M descendants (green) during L2–L4 development. Nuclei are marked with DAPI (blue).
Scale bars, 20 mm. See also Figure S4 and Tables S3 and S4.
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extensively characterized in previous experiments (Boyle et al.,
2014; Lei et al., 2010). Visual inspection of promoter regions
showed strong overlap between SWI/SNF and HLH-1 occu-
pancy, not only at muscle-specific genes (e.g., myo-3 myosin),
but also at several positive (cdk-4, cye-1) and negative (cki-1,
cki-2, cdc-14) G1 regulatory genes (Figure S6). Using a temper-
ature sensitive hlh-1 MyoD allele, we observed that partial hlh-1
loss of function at 25C resulted in increased numbers of M de-
scendants around the vulva, to a similar extent as hlh-1, swsn-1
double mutants (Figure 5A; Table S4). While this supports
a concerted function, the hlh-1(cc561ts) phenotype resulted
largely from SM duplication, whereas extra M-lineage divisions
following swsn-1 loss appeared more random (Figure 4F).
When combined with lin-23 RNAi, the hlh-1 mutation caused
severe over-proliferation to a similar degree as mesoblast-spe-
cific swsn-1 inactivation (Figure 5B; Table S4). Combining
hlh-1(cc561ts) and swsn-1 knockout with lin-23(RNAi) further
increased M-lineage proliferation, which may reflect incomplete
loss of function or point to partially non-overlapping contribu-
tions of hlh-1 and swsn-1. Nevertheless, the substantial overlap
in over-proliferation phenotypes indicates that SWI/SNF and
HLH-1 MyoD act together to induce cell-cycle arrest in the
transition of proliferating precursor cells to differentiated post-
mitotic muscle cells.
SWI/SNF Antagonizes PcG Gene Function and Controls
Positive and Negative Cell-Cycle Regulators
SWI/SNF chromatin remodeling has been proposed to antago-
nize transcriptional repression by Polycomb group (PcG) pro-
teins. C. elegans uses a protein complex of MES-2, MES-3 and
MES-6 with similarity to the Polycomb Repressive Complex 2
(PRC2) (Gaydos et al., 2012). We observed that RNAi of the
PcG-related genes mes-2 EZH2 and mes-3 significantly sup-
pressed over-proliferation induced by swsn-1 mutation or fzr-1,
swsn-1 double mutation (Figure 5C; Table S4). Thus, the over-
proliferation phenotype may result from PcG-mediated repres-
sion of genes that normally are SWI/SNF-dependently induced
during muscle differentiation.
When combinedwithM-lineage-specific fzr-1 and swsn-1 inac-
tivation, strong RNAi of mes-2 EZH2 or mes-3 reduced the extra
divisions only in part (Figure 5C). As loss of fzr-1 alone does not
alter the M lineage, these observations appear to indicate that
SWI/SNF also has functions unrelated to antagonizing PcG.
C. elegans SWI/SNF proteins occupy promoters of positive as
well as negative regulators of cell division (Figure S5; Riedel
et al., 2013). Hence, the SWI/SNF complex could stimulate cell-
cycle exit through transcriptional activation of G1/S inhibitors,
and in addition through transcriptional silencing of cell-cycle
entry promoting genes such as cye-1 Cyclin E. To examine
this possibility, we created a cye-1 transcriptional reporter. This
Pcye-1::tagBFP reporterwasexpressed inpost-mitoticM-derived
muscle cells of lineage-specific swsn-1 mutants, in contrast to
the corresponding cells in wild-type control animals (Figures 5D
and 5E). These data support SWI/SNF-mediated transcriptional
repression of cye-1 cyclin E during cell-cycle withdrawal.
To extend these observations, we performed single-molecule
FISH (smFISH) experiments for positive (cye-1, cdk-4) and
negative (cki-1, cdc-14) cell-cycle regulators identified as poten-tially SWI/SNF and HLH-1-regulated genes (Figure S6). We also
included myo-3 myosin as an example of a probable SWI/SNF
and HLH-1 MyoD-regulated muscle-specific gene (Figure S6).
cyd-1Cyclin Dwas not identified as a SWI/SNF target in previous
ChIP experiments and served as a control (Figure S5; Riedel
et al., 2013). Simultaneous smFISH labeling with anti-eGFP
probes helped visualize theM-derivedmuscle cells in readoutlox;
Phlh-8::CRE control animals and swsn-1lox;Phlh-8:CREmutants
(Figure 5F).
We detected cye-1 and cdk-4 mRNA expression in post-
mitotic muscle cells of M-lineage-specific swsn-1 mutants
(Figure 5G). The corresponding muscle cells in control animals
basically did not express cye-1 mRNA, and showed signifi-
cantly fewer cdk-4 mRNA molecules. Conversely, the numbers
of cki-1, cdc-14, and myo-3 mRNA molecules in M-lineage
muscle cell were substantially reduced in swsn-1 mutants,
compared to wild-type controls (Figures 5G and 5H). Neither
the control nor swsn-1 mutants expressed cyd-1 mRNA in ar-
rested M-lineage muscle cells (Figure 5G). Thus, only the G1/
S regulator genes with a SWI/SNF-occupied promoter showed
significantly induced (cye-1 and cdk-4) or reduced (cki-1 and
cdc-14) expression following swsn-1 inactivation. Importantly,
the cye-1 transcript numbers further increased when the
swsn-1 mutation was combined with a lin-35(n745) mutation
(Figure 5G). This observation lends support for independent
yet cooperative functions of SWI/SNF and lin-35 Rb complexes
in cye-1 cyclin E repression. Together, these results support
that the SWI/SNF complex contributes to both positive and
negative regulation of cell-cycle gene expression during muscle
differentiation.
Combined G1/S Inhibitor and SWI/SNF Loss Leads to
Continued Proliferation of Muscle Precursors
The over-proliferating cells could remain present as undifferenti-
ated precursor cells, could become highly undifferentiated, or
could obtain an in-between or random fate. To distinguish be-
tween these possibilities, we examined several markers for
M-lineage descendants. The HLH-8 Twist transcription factor
is expressed in undifferentiated precursor cells of the M lineage,
but not in the differentiated muscle cells and coelomocytes
(Corsi et al., 2000). We examined expression of a Phlh-8::tagBFP
transcriptional reporter in the readoutlox strain and twoM-lineage
mutant strains (Figures 6A–6C). Expression of tagBFP was
apparent in all precursor cells of the M lineage, including the
migrating sex myoblasts (SM). However, at the time of muscle
differentiation, tagBFP expression disappeared (Figure 6A). In
swsn-1 M-lineage knockout mutants treated with lin-23 RNAi,
approximately half of the daughter cells maintained Phlh-8-
8::tagBFP expression, even at late larval stages. This number
increased considerably when swsn-1 lin-23 double inactivation
was combinedwith fzr-1 loss (49.8%versus 81.7% tagBFP-pos-
itive M descendants in the double versus triple mutant, respec-
tively; Figures 6B and 6C; Figure S7). Thus, increased prolifera-
tion in the M lineage correlated with a higher percentage of M
descendants maintaining expression of the hlh-8 Twist precur-
sor cell reporter.
We also examined actin and UNC-15 paramyosin expression




Figure 5. Control of Cell-Cycle Arrest and Differentiation by SWI/SNF Chromatin Remodeling
(A and B) Quantification of the number of mesoblast descendants in wild-type and hlh-1(cc561ts) animals at the non-permissive temperature, combined with
lineage-specific inactivation of swsn-1 (A) and/or lin-23 RNAi (B).
(C) Quantification of mesoblast descendants around the vulva in swsn-1 or fzr-1; swsn-1 mutants in combination with mes-2 EZH2 or mes-3 RNAi.
(D) Quantification of the percentage post-mitotic muscle cells expressing Pcye-1::tagBFP in WT and mutants with M-lineage-specific swsn-1 inactivation.
(E) Representative fluorescence microscopy images of animals quantified in (D).
(F) smFISH staining using Cy5-labeled probes for myo-3 and TMR-labeled probes for GFP.
(legend continued on next page)
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visualized by immunohistochemical analysis, the eGFP-positive
M-lineage-derived body-wall muscle cells intercalated with the
embryonic body muscles and formed well-organized myofila-
ments (Figures 6D and 6F, top). The eGFP positive M descen-
dants in lin-23(RNAi) fzr-1lox;swsn-1lox;Phlh-8::CRE mutants
rarely showed organized myofilaments, and the majority did
not show detectable actin or UNC-15 paramyosin expression
(Figures 6D–6G and S7). However, muscle markers were
expressed in some cells, and the percentage of actin or para-
myosin expressing cells was substantially higher in lin-
23(RNAi);swsn-1lox;Phlh-8::CRE mutants with wild-type fzr-1,
compared to mutants that also lacked fzr-1 function. This is
consistent with the proliferating M-lineage cells either maintain-
ing progenitor status or initiating incomplete muscle differentia-
tion. These observations highlight the inverse regulation of cell
proliferation and differentiation.
DISCUSSION
Our experiments based on CRE-lox mediated recombination
and lineage tracing uncovered tissue-type-specific regulatory
mechanisms for cell division arrest that cause tumorous over-
proliferation of somatic cells when deregulated in C. elegans.
We found five distinct levels of control to contribute to cell-cycle
exit: CDK inhibitory protein expression, LIN-35 Rb-mediated
transcriptional repression, APC/CFZR-1 and SCFLIN-23 catalyzed
protein degradation, and SWI/SNF-mediated chromatin remod-
eling. These controls appear largely redundant and partly addi-
tive, together creating a highly robust decision to exit the cell
division cycle. The contribution of SWI/SNF mediated chromatin
remodeling is critical, as excessive over-proliferation occurred
only when inactivation of G1/S inhibitors was combined with
SWI/SNF gene loss. Our data together with the describedmolec-
ular functions support a model in which the different G1/S inhib-
itors and SWI/SNF complex provide alternative mechanisms to
block the cell-cycle machinery, converging at the CDK-4/Cyclin
D and CDK-2/Cyclin E kinases and initiation of DNA synthesis
(Figure 7).
The cell-cycle arrest network is complex, because the regula-
tors involved act redundantly, have multiple substrates, and
provide feedback control. The Rb/E2F and SWI/SNF complexes
affect the transcription of many genes, and the APC/CFZR1 and
SCFLIN-23 E3 ligases target multiple proteins for degradation.
Nevertheless, a limited number of regulatory steps may be
crucial for cell-cycle exit. We found LIN-35 Rb and SWI/SNF to
converge on cye-1 Cyclin E transcriptional repression, while
CKI-1 likely blocks CDK-2/CYE-1 Cyclin E kinase activity. More-
over, CUL-1 and LIN-23 b-TrCP have been implicated in G1
cyclin protein degradation (Kipreos et al., 1996, 2000), while
experimental evidence points to SCFLIN-23 catalyzed degrada-
tion of the CDK-cyclin activating phosphatase CDC-25.1 (He-
beisen and Roy, 2008). Targets of the APC/CFZR-1 are currently(G and H) Detection of cell-cycle and muscle-specific gene transcripts using smF
mRNAs in post-mitotic muscle cells of the indicated genotypes.
Arrows indicate differentiated M-lineage muscles (green). Graphs show mean ± S
lines (A–C) indicate average WT numbers. Scale bars, 20 mm in (E) and 5 mm in (not known in C. elegans. Our recent results indicate that FZR-1
and LIN-35 pRb are the most critical substrates of CDK-4/cyclin
D kinases (The et al., 2015). As such, combined loss of lin-35 Rb
and fzr-1 alleviates cell-cycle arrest by bypassing the require-
ment for CDK-4/cyclin D kinase activity. Mesoblast descendants
do not continue proliferation in lin-35 Rb, fzr-1 double mutants,
which likely reflects requirement for CDK-2/Cyclin E activation
for S phase initiation. In the double mutants, CDK-2/Cyclin E ac-
tivity is still inhibited through CKI-1 Kip1 association, SCFLIN-23-
induced degradation of CDC-25.1, and SWI/SNF-dependent
cyclin E transcriptional repression. Such alternative and partly
non-overlapping levels of G1 CDK-cyclin inhibition can explain
the observed genetic interactions between the different regula-
tors (Figure 7).
SWI/SNF chromatin remodeling complexes act as global reg-
ulators of transcription. Drosophila SWI/SNF genes were identi-
fied as TrxG members with a positive role in Homeotic (HOX)
gene expression or antagonism of PcG-mediated silencing
(Schuettengruber et al., 2011). Suppression of the swsn-1
over-proliferation phenotype by PcG-related gene knockdown
indicates that the antagonism between SWI/SNF and PcG
gene function is conserved in C. elegans. Re-introduction of
human SNF5 (BAF47/INI1) in SNF5 mutant rhabdoid tumor cells
was found to induce PcG complex removal, transcription of the
p16INK4A and p21CIP1 genes, and cell proliferation arrest (Chai
et al., 2005; Kia et al., 2008; Kuwahara et al., 2013). Similarly,
our results could be explained by PcG-mediated silencing of
G1/S inhibitor genes that are normally activated by the SWI/
SNF complex. However, this cannot explain the enhanced
expression of positive cell-cycle regulators in the swsn-1mutant.
Transcriptional suppression by SWI/SNF-mediated chromatin
remodeling could indirectly result from an induced factor, as
has recently been described in Drosophila neural stem cells
(Eroglu et al., 2014). In contrast, our data, based on SWI/SNF
promoter occupancy combined with reporter expression and
smFISH experiments, support a direct contribution of SWI/
SNF-mediated chromatin remodeling in transcriptional repres-
sion of cye-1 and cdk-4. Together, these data are consistent
with the model that SWI/SNF-mediated chromatin remodeling
antagonizes PcG and promotes transcription of negative cell-
cycle regulators during differentiation, while simultaneously
acting in cooperation with pRb to repress the transcription of
positive regulators.
We found SWI/SNF gene function to be crucial for cell-cycle
arrest in the mesoblast lineage, but not in the intestine.
Notably, differentiated embryonic intestinal cells do not exit
the cell cycle as they continue nuclear divisions and rounds
of DNA synthesis during larval development (Hedgecock
and White, 1985). In contrast, cells in the M-lineage transition
from proliferating precursors to terminally differentiated post-
mitotic cells (Sulston and Horvitz, 1977). This transition com-
bines cell-cycle withdrawal with activation of a muscle-specificISH, showing the number of fluorescent spots corresponding to the indicated
EM; each dot represents a single animal (A–C) or single cell (G and H). Dotted
F). See also Figures S5 and S6 and Tables S3 and S4.




Figure 6. Limited Differentiation of Over-Proliferating Mesoblast Descendants
(A and B) Fluorescence microscopy images showing hlh-8 Twist promoter activity (tagBFP, Blue) in M-daughter cells (eGFP-positive, green). (A) Wild-type
control, tagBFP is visible in precursor cells (arrows), but not in differentiated muscle cells (arrowheads). Asterisks (*) indicate the position of the vulva. (B) fzr-1lox;
swsn-1lox; lin-23(RNAi) mesoblast mutant. M-derived cells with Phlh-8::tagBFP expression are indicated by arrows, without Phlh-8::tagBFP expression with a
arrowhead.
(C) Percentage of green cells positive for Phlh-8::tagBFP in animals of the indicated genotypes (bottom).
(D and F) Staining of muscle differentiation markers, actin (red) (D), and paramyosin (red) (F) in L4 wild-type and mutant larvae. GFP: mesoblast descendants are
visualized by anti-GFP antibody staining (green), nuclei by DNA staining (DAPI, blue). Arrows indicate non-mesoblast-derived differentiated muscle cells (GFP
(legend continued on next page)
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Figure 7. Model for Developmental Arrest of
Cell Division
Ub-dependent protein degradation, Rb-mediated
transcriptional repression, and association of
CDK-inhibitory proteins with CDK/cyclin com-
plexes promote cell-cycle arrest. During terminal
differentiation, SWI/SNF complexes in coopera-
tion with lineage-specific transcription factors
provide an additional level of control. The different
G1/S inhibitors and SWI/SNF complex cooperate
by providing alternative levels of control over the
basic cell-cycle regulators, with each level antag-
onizing CDK-4/CYD-1 cyclin D and/or CDK-2/
CYE-1 cyclin E kinase activity. Together, these
regulators provide a highly robust control network
for cell-cycle exit. See also Figures S5 and S6.gene expression program. Previous studies of differentiating
myoblasts implicated SWI/SNF-mediated chromatin remodel-
ing in muscle-specific gene expression (Puri and Mercola,
2012; de la Serna et al., 2001). This activation of cell-type-
specific gene expression likely coincides with SWI/SNF-medi-
ated chromatin remodeling at cell-cycle gene promoters (see
above; Figure 7). Transcriptional activation and inactivation of
cell-cycle genes by the SWI/SNF complex provides a mecha-
nism for cell-cycle exit that may be employed specifically
during terminal differentiation, and which still can be effective
when multiple G1/S inhibitors are lost. This could be the
main difference between permanent cell-cycle arrest and tem-
porary quiescence.
Recent cancer genome sequencing studies and identification
of additional SWI/SNF accessory and signature factors have
revealed that inactivation of SWI/SNF components occurs in a
broad spectrum of human cancers, at an astonishing average
frequency of nearly 20% (Kadoch et al., 2013; Kandoth et al.,
2013; Wang et al., 2014). The mutation frequencies vary greatly
among SWI/SNF subunits and cancer types, emphasizing the
importance of cellular context and SWI/SNF complex composi-
tion. Selective pressure in cancer can be expected to particularly
benefit mutations that prevent early lineage transitions and
maintain an immortal stem or progenitor state. At the same
time, mutations that sustain cell proliferation are near universally
present in human cancer (Hanahan and Weinberg, 2011).
Further studies will be needed to understand the cell-type-spe-
cific and combinatorial activities of SWI/SNF components and
transcription factors in proliferation versus differentiation deci-




The genotypes of all strains used in this study are listed in Table S7.absent); arrowheads indicate mesoblast descendants (green) expressing actin (re
actin (red) or paramyosin (red).
(E and G) Percentage of cells with well-organizedmyofilaments (light gray), aberra
gray) based on actin (E) or paramyosin (G) staining in animals of the indicated ge
Graphs show mean ± SEM. Scale bars, 20 mm. See also Figure S7.RNA-Mediated Interference and Molecular Cloning
Detailed descriptions of the RNAi procedures and all vector and transgene
constructions are included in the Supplemental Experimental Procedures.
Immunohistochemical Analysis
For immunostaining with antibodies, animals were fixed using the Bouin’s
fixative protocol and stained according to standard protocol. EdU incor-
poration and detection was used to visualize DNA replication during
later stages of development (van den Heuvel and Kipreos, 2012). Subse-
quently, immunostaining with antibodies was performed to identify GFP-
positive cells. See Supplemental Experimental Procedures for detailed
descriptions.
Microscopy and Quantification of Cell Numbers
Cell division events were quantified by counting the number of GFP-positive
cells in the intestine or mesoblast lineage. For relatively weak phenotypes,
mesoblast descendants were counted in the region around the vulva. For
stronger phenotypes, we counted the total number of eGFP-positive cells,
as indicated in the text and figures. Image acquisition and quantifications of
mesoblast descendants expressing the Pcye-1::tagBFP or Phlh-8::tagBFP
transcriptional reporters, UNC-15 paramyosin or actin are described in the
Supplemental Experimental Procedures.
Single-Molecule Fluorescence in Situ Hybridization
Probes for RNA single-molecule fluorescence in situ hybridization (smFISH)
were ordered fromStellaris (http://singlemoleculefish.com/). For quantification
of the number of mRNA molecules, the presence of tetramethylrhodamine
(TMR) (eGFP) spots was used to draw a region of interest around M-lineage
muscle. The number of Cy5 fluorescent mRNA spots was quantified in this
region. Further experimental details are provided in the Supplemental Experi-
mental Procedures.
Statistical Analysis
Sample sizes were not pre-determined; instead, all available animals of the
right stage and genotype were counted. smFISH data are included from at
least eight independent animals, reporter expression and cell numbers from
at least ten independent animals. Graphs and data analysis were produced
using GraphPad Prism 5. Plots indicate all data points, as well as the mean
(average) ± SEM. As the data essentially fit normal distributions, unpaired
two-tailed Student’s t tests were used to examine statistical significance of
the difference between means.d) or paramyosin (red). *Mesoblast descendants (green), without expression of
nt morphology of myofilaments (middle gray), or absence of myofilaments (dark
notypes (bottom).
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